KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 114 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $124,000 | +61.0% | 12,865 | 0.0% | 0.17% | +83.5% |
| Q2 2019 | $77,000 | -9.4% | 12,865 | -11.5% | 0.09% | -22.9% |
| Q1 2019 | $85,000 | -65.9% | 14,532 | -45.2% | 0.12% | -64.9% |
| Q4 2018 | $249,000 | -16.7% | 26,529 | +51.2% | 0.34% | +20.0% |
| Q3 2018 | $299,000 | -14.8% | 17,540 | -15.2% | 0.28% | -13.0% |
| Q2 2018 | $351,000 | – | 20,672 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 3,561,052 | $26,245,000 | 5.86% |
| Palo Alto Investors LP | 5,621,533 | $41,431,000 | 3.20% |
| Iron Triangle Partners LP | 2,000,000 | $14,740,000 | 1.75% |
| Altium Capital Management LP | 645,000 | $4,754,000 | 1.59% |
| Birchview Capital, LP | 269,332 | $1,985,000 | 1.43% |
| Rubric Capital Management LP | 3,607,443 | $26,587,000 | 0.96% |
| Lombard Odier Asset Management (Switzerland) SA | 776,053 | $5,720,000 | 0.45% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,344,929 | $9,912,000 | 0.40% |
| Golden State Equity Partners | 41,850 | $308,000 | 0.16% |
| Hennion & Walsh Asset Management, Inc. | 385,837 | $2,844,000 | 0.15% |